Research progress and future perspectives of anticancer drug-induced interstitial lung disease/pneumonia in gastric cancer
Gastric cancer presents a high incidence rate and substantial disease burden, posing significant therapeutic challenges. Recent advances have yielded significant benefits for gastric cancer patients through novel anti-tumor agents, including immune checkpoint inhibitor (ICI), human epidermal growth...
Enregistré dans:
| Auteurs principaux: | , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Editorial Office of China Oncology
2025-09-01
|
| Collection: | Zhongguo aizheng zazhi |
| Sujets: | |
| Accès en ligne: | http://www.china-oncology.com/thesisDetails#10.19401/j.cnki.1007-3639.2025.09.008 |
| Tags: |
Pas de tags, Soyez le premier à ajouter un tag!
|